COLLECTION OF FAECAL SAMPLES


Sampling of faecal calprotectin; general advice

In proctitis the area of inflamed mucosa is very limited and the contact time between stool and tissue may be short, especially if the sample is collected late in the day and not from the first defecation. In this situation the intestinal content may pass the short inflamed area very rapidly, not allowing “the incubation time” in the gut to be sufficient for delivery of calprotectin into the stool. This is the reason why it is recommended that samples for calprotectin determination should be collected from the first defecation in the morning, thereby ensuring that “the incubation time” is sufficient. Lasson et al.  studied fecal calprotectin in patients with active ulcerative colitis, samples were collected from consecutive defecations during the day. They found that the levels are highest in samples collected when there is long time between the defecations. It is concluded that the sampling should be the same from day to day, preferably in the morning.

CALPRO TEAM

  • Anne Thjømøe

    Executive Chairman 

    Mail: athjomoe@calpro.no

    Direct line: +47 97 73 37 51

  • Inge Dale

    M.D., Ph.D. Chief Medical Officer

    E-mail: idale@calpro.no

    Direct line: +47 91 31 45 03

  • Anne Hancke Framstad

    Laboratory Quality Specialist

    E-mail: aframstad@calpro.no

    Direct line: +47 92 01 14 91

  • Einar Mørk

    Dir. Operations

    E-mail: einar@calpro.no

    Direct line: +47 47 28 55 61

  • Mona Schartum

    Production Manager

    E-Mail: mona.schartum@calpro.no

    Direct line: +47 93 22 73 63

  • Ingvild Haukø

    Sales- and Marketing Manager

    e-mail: ingvild@calpro.no

    Direct line: +47 92 01 52 18

  • Ali Qamar

    Product Manager

    E-mail: ali@calpro.no

    Direct line: +47 41 17 81 19

General Information

Fecal calprotectin in differential diagnosis of irritable bowel syndrome

Li XG, Lv YM, Gu F, Yang XL., Department of Gastroenterology, Peking University Third May 9, 2015

PhiCal Test FDA approved

The PhiCal Test has now been approved by the FDA for clinical use in the USA October 1, 2014

Latest News

Calpro press release regarding MSD agreement

Please see the Calpro press release regarding MDS agreement for delivery of e-health technology CalproSmart:

Norsk | English October 13, 2016

Calprosmart in the Media

Please see our latest articles regarding CalproSmart in Aftenposten and LMF Norge

LMF Norge | Aftenposten October 12, 2016

View all latest